Affordable Insulin Now Act of 2026
Official title: A bill to provide for appropriate cost-sharing for insulin products covered under private health plans, and to establish a program to support health care providers and pharmacies in providing discounted insulin products to uninsured individuals.
What Do You Think?
How would you vote?
Vote to see the result.
What Happened in Congress?
Not yet voted on the floor.
Where the Bill Stands
- Introduced, done
- Committee, current stage
- Floor Vote, not yet
- Outcome, not yet
What This Bill Does
This bill limits cost-sharing for insulin under private health insurance and establishes a program to provide insulin to individuals without insurance.
Specifically, the bill caps cost-sharing under private health insurance for a month's supply of selected insulin products at $35 or 25% of a plan's negotiated price (after any price concessions), whichever is less, beginning in 2027.
Further, the Department of Health and Human Services (HHS) must enter into agreements with pharmacies or health care providers to provide insulin to individuals without insurance. HHS must pay such pharmacies or providers an amount equal to the difference between the out-of-pocket cost to the individual for a 30-day supply of such insulin products and $35.
Sponsors
Related Documents
Timeline
- Library of CongressIntroduced in Senate
- SenateRead twice and referred to the Committee on Health, Education, Labor, and Pensions.
- Introduced
- Committee

Comments
Comments with insults, hate speech or personal information are removed.